✦ LIBER ✦

Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion

✍ Scribed by P. H. Astoul; P. Bertault-Peres; A. Durand; J. Catalin; F. Vignal; C. Boutin

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 518 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940115)73:2<308::aid-cncr2820730213>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intrapleural immunotherapy with escalati

Intrapleural immunotherapy with escalating doses of interleukin-2 in metastatic pleural effusions

✍ J. R. Viallat; C. Boutin; F. Rey; Ph Astoul; P. Farisse; M. Brandely 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB

Background. The authors assessed the tolerance and efficacy of intrapleural interleukin-2 (IL-2) in patients with malignant effusion. Methods. Twenty-three patients had a total of 25 metastatic pleural effusions; the patients were treated with recombinant IL-2 by means of a continuous intrapleural

Intrapleural adaptive immunotherapy for

Intrapleural adaptive immunotherapy for breast cancer patients with cytologically-confirmed malignant pleural effusions: an analysis of 67 patients in Kyoto and Shiga Prefecture, Japan

✍ Norimichi Kan; Hiroshi Kodama; Taisuke Hori; Atsushi Takenaka; Tadaki Yasumura; 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 639 KB

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Philippe Astoul; Diane Picat-Joossen; Jean-Regis Viallat; Christian Boutin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 3 views

## Background: The prognosis associated with malignant pleural mesothelioma (mpm) is poor in spite of surgery, radiotherapy, photodynamic therapy, or chemotherapy. therefore, new therapeutic strategies, including intrapleural immunotherapy, are being investigated. several clinical studies have demo

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Theodore G. Karrison; Nicholas J. Vogelzang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Stage I Renal Cell Carcinoma I read the report by Kinouchi et al., 1 in which they concluded that the tumor grading of renal cell carcinoma was not predictive of the survival of Robson Stage I patients. This does not mean that the three-grading system is worthless; the authors simply showed tha